Overview
Status
Active
Registry date
2023-06-16
Share capital
50,000.00 PLN
Registered address
ul. Akacjowa 1, 62-025 Kostrzyn, Poland
Electronic delivery address
AE:PL-15009-23478-BEUEA-18
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2023, 1 day late).
- 2025not filed
- 202403/07/2025
- 202316/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Voivodeship · Wielkopolskie49,004 / 49,541
Top 99%
Country · Poland489,926 / 495,935
Top 99%
Results vs industry
Revenue
This companyUSD 0.13MedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD -2.36kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 2.36kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 13.17kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Sandra Żywicka-Sztulage 38 – President of the Management Board
Manner of representation
If the management board consists of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-09-01.
92 1050 1520 1000 0090 8542 7541- 54 1050 1520 1000 0090 3297 2177
- 52 1050 1520 1000 0090 8542 7582
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 23, 2025 | Aid for research and development projects: industrial research | $494.2K$494,168 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Sep 23, 2025 | Aid for research and development projects: experimental development | $283.8K$283,787 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-12-01 | Development of an innovative human milk fortifier based on human milk, intended for prematurely born infants | $979K$978,959 | European Funds for a Modern Economy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Innervisionsp. z o.o. | $4.54 | innervision.pl | ||
| ImmunotronicsP.S.A. | $0.16 | immunotronics.net | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
Last updated: 2026-04-02